Hayden Jeffreys

Dec 02, 2016

ERBA Diagnostics has appointed Hayden Jeffreys as interim CEO, effective Jan. 1, 2017. The employment agreement of the company's current CEO Mohan Gopalkrishnan expires on Dec. 31. Jeffreys has served on ERBA's board of directors since May 31, and also serves as the commercial director for the molecular diagnostics division and as vice president of business development and strategy for ERBA Diagnostics Mannheim. He plans to continue in those capacities. Prior to joining ERBA Mannheim, Jeffreys served in a variety of positions for several diagnostics companies, including Lumora, Lab21 Healthcare, Invitron, Kronus, and Gen-Probe UK (now Hologic).

Hayden Jeffreys

Sickle Cell Trait Carriers Run Higher Risk of Blood Clots Regardless of Ancestry

Inflammatix Raises $57M in Series E Financing

Pacific Biosciences Helps Launch Sequencing-Based Fertility Research Consortium in Asia

Ovarian Aging Study Finds Rare Variant Contributors With Ties to DNA Damage Response, Cancer

Agena Bioscience Expands Into South America With Distribution Deals in Argentina, Brazil